By David R. Henderson published in The Wall Street Journal with commentary from Michael Lerner This WSJ Op Ed on why the FDA is attacking ivermectin is a significant cultural moment in the debate over the drug. Like the NY Times, the Wall Street Journal has an...
Why Is the FDA Attacking a Safe, Effective Drug?
read more